# Preoperative Planning With PSMA-PET in Melanoma Surgery Trial

> **NCT06560905** · PHASE2 · RECRUITING · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 16 (estimated)

## Conditions studied

- Malignant Melanoma

## Interventions

- **DRUG:** 68Ga-PSMA

## Key facts

- **NCT ID:** NCT06560905
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-11
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06560905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06560905, "Preoperative Planning With PSMA-PET in Melanoma Surgery Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06560905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*